Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia

We reviewed the outcome of 671 patients 65 years of age or older with newly diagnosed acute myeloid leukemia (AML) treated at our institution between 2000 and 2010 with intensive chemotherapy (n = 557) or azacitidine- or decitabine-based therapy (n = 114). Both groups were balanced according to cyto...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Quintás-Cardama, Alfonso, Ravandi, Farhad, Liu-Dumlao, Theresa, Brandt, Mark, Faderl, Stefan, Pierce, Sherry, Borthakur, Gautam, Garcia-Manero, Guillermo, Cortes, Jorge, Kantarjian, Hagop
Format: Artigo
Język:Inglês
Wydane: American Society of Hematology 2012
Hasła przedmiotowe:
Clinical Trials and Observations
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3952725/
https://ncbi.nlm.nih.gov/pubmed/23071272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-06-436055
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy